Home › NDC Lookup › RxCUI directory › RxCUI 1115464

1 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe [Lupron] — RxCUI 1115464

RxNorm drug concept · Semantic branded drug
RxCUI 1115464 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1115464
Official name1 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe [Lupron]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1 ML Lupron 7.5 MG/ML Prefilled Syringe; Lupron Depot 7.5 MG in 1 ML (1 month) Prefilled Syringe; Lupron Depot 7.5 MG per 1 ML (1 month) Prefilled Syringe
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)25,009 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Leuprolide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product prescribed. Fensolvi is used for children 2 and older who are going through puberty too early — a condition called central precocious puberty. Products li...
  • What exactly is leuprolide injection used for?
  • This is called a tumor flare, and it's actually expected. In the first one to two weeks, testosterone levels temporarily rise before the medication brings them down. For men with p...
  • Why might symptoms get worse right after starting the injection?
📖 Read our full Leuprolide Injection guide →

🕸️ Concept Web — How 1 ML leuprolide acetate 7.5 MG/ML Prefilled Syri... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe [Lupron] RxCUI 1115464

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Leuprolide 42375
    • Leuprolide acetate 203217
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lupron 203852
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Leuprolide Prefilled Syringe 727599
    • Leuprolide acetate Prefilled Syringe 2648637
    • Leuprolide Injectable Product 1163443
    • Leuprolide acetate Injectable Product 2659197
    • Leuprolide Prefilled Syringe [Lupron] 727602
    • Leuprolide acetate Prefilled Syringe [Lupron] 2655467
    • Lupron Injectable Product 1181489
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1 ML leuprolide acetate 7.5 MG/ML Prefilled Syringe SCD · 1115462
  • Leuprolide acetate 7.5 MG/ML SCDC · 1115461
  • Leuprolide Prefilled Syringe SCDF · 727599
  • Leuprolide acetate Prefilled Syringe SCDFP · 2648637
  • Leuprolide Injectable Product SCDG · 1163443
  • Leuprolide acetate Injectable Product SCDGP · 2659197

Brand-Name Concepts

  • Leuprolide acetate 7.5 MG/ML [Lupron] SBDC · 1115463
  • Leuprolide Prefilled Syringe [Lupron] SBDF · 727602
  • Leuprolide acetate Prefilled Syringe [Lupron] SBDFP · 2655467
  • Lupron Injectable Product SBDG · 1181489
  • Lupron BN · 203852

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 1115464 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00074-3346-03 1 KIT in 1 CARTON (0074-3346-03) * 1.5 mL in 1 SYRINGE (00... Lupron Depot AbbVie Inc. 1995-12-23
00074-3346-55 1 KIT in 1 CELLO PACK (0074-3346-55) * 1.5 mL in 1 SYRINGE... Lupron Depot AbbVie Inc. 2026-03-15
00074-3473-03 1 KIT in 1 CARTON (0074-3473-03) * 1.5 mL in 1 SYRINGE (00... Lupron Depot AbbVie Inc. 1995-12-23
00074-3473-55 1 KIT in 1 CELLO PACK (0074-3473-55) * 1.5 mL in 1 SYRINGE... Lupron Depot AbbVie Inc. 2026-03-15
00074-3642-03 1 KIT in 1 CARTON (0074-3642-03) * 1 mL in 1 SYRINGE (0074... Lupron Depot AbbVie Inc. 1989-01-27
00074-3642-55 1 KIT in 1 CELLO PACK (0074-3642-55) * 1 mL in 1 SYRINGE (... Lupron Depot AbbVie Inc. 2026-03-15
00074-3683-03 1 KIT in 1 CARTON (0074-3683-03) * 1.5 mL in 1 SYRINGE (00... Lupron Depot AbbVie Inc. 1995-12-23
00074-3683-55 1 KIT in 1 CELLO PACK (0074-3683-55) * 1.5 mL in 1 SYRINGE... Lupron Depot AbbVie Inc. 2026-03-15
Observed labelers: AbbVie Inc. (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9217 Leuprolide acetate suspnsion 4 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.